Case File
efta-efta01760936DOJ Data Set 10CorrespondenceEFTA Document EFTA01760936
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01760936
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Wednesday, March 27, 2013 7:43 PM
To:
Jeffrey Epstein
Subject:
cymbalta etc
Should I still be going down to 30mg of CYMbalta from my current 60mg even =hough I did not like the xanax.
What should our plan of action be now?=a new ssri?
Should I see someone?
I thi=k I would have to see someone new as the previous one was so stingy with p=escriptions, he will only give them for
a month at a time and wants to see=you all the time.
1
EFTA_R1_00065386
EFTA01760936
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.